Runhui Lu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Targeting the TRIM25-AGO2-miR-148b-5p-ABCC1 axis overcomes chemoresistance in non-small cell lung cancer.
Journal: Cell death & disease
Published: October 20, 2025
SUMOylation of SND1 drives mature miRNA degradation and tumor progression.
Journal: Cancer letters
Published: September 10, 2025
A novel regulatory axis of MSI2-AGO2/miR-30a-3p-CGRRF1 drives cancer chemoresistance by upregulating the KRAS/ERK pathway.
Journal: Neoplasia (New York, N.Y.)
Published: September 15, 2024
The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs.
Journal: Nucleic acids research
Published: June 24, 2024
Loss of Fbxo45 in AT2 cells leads to insufficient histone supply and initiates lung adenocarcinoma.
Journal: Cell death and differentiation
Published: June 14, 2024
N4-acetylcytidine modifies primary microRNAs for processing in cancer cells.
Journal: Cellular and molecular life sciences : CMLS
Published: October 11, 2023
Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 09, 2023
Glucose-mediated N-glycosylation of RPTPα affects its subcellular localization and Src activation.
Journal: Oncogene
Published: January 27, 2022
SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Journal: Nucleic acids research
Published: September 19, 2020
Hypoxia regulates overall mRNA homeostasis by inducing Met1-linked linear ubiquitination of AGO2 in cancer cells.
Journal: Nature communications
Published: September 11, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026